(b)(4).Investigation summary: level b investigation - complaint evaluation / complaint history check for the event(s) that occurred.Severity: s_1__; occurrence: a complaint history check was performed and this is the 1st related complaint for difficult/unable to operate (not drawing) on lot # 9200478.This is an mds product, risks, hazards and harms are captured under the umbrella of risk management document (b)(4).Investigation summary: customer returned (1) 1/2ml, 8mm, 30g bd safetyglide insulin syringe from lot # 9200478.Customer states that it is unable to draw medication.The retuned syringe was tested and was able to draw and expel properly without any observed defects.A review of the device history record was completed for batch# 9200478.All inspections and challenges were performed per the applicable operations qc specifications.There were zero (0) notifications noted that pertained to the complaint.Investigation conclusion: based on the samples and/or photo(s) received the investigation concluded: unconfirmed: bd was not able to duplicate or confirm the customer¿s indicated failure.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Root cause description: root cause cannot be determined at this time as the issue is unconfirmed.Rationale: based on the investigation, no additional investigation and no capa is required at this time.
|